Turnover
≈ €190,000 estimated
The micro format states no turnover.
BUCAMED
Lifetime
17 annual accounts with figures on one time axis, 18 filings since 2008peak €90,599 (2021)
€82,995▲ 15.8%
lowest -€48,456 (2016)
€27,588▲ 37.9%
peak €123,139 (2014)
€121,076▲ 29.5%
€536,067▼ 6.7%
peak 0.8 FTE (2011)
-not published
Board2 names since 2015
1 director
Owners
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Gross margin from €71,684 to €82,995Result from €20,005 to €27,588Equity from €93,488 to €121,076
Key points
from the 2025 annual accountsDebts
€536,067 82% of the balance sheet
Financial debts 79%Suppliers 0%Taxes and wages 2%Other 18%
Of this, €111,492 falls due within a year.
Position in the sector
18.4%
Lower solvency than 81% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 4,107 companies had the same profile as BUCAMED has now. Each dot stands for 11 companies, two years later.
97.9%
were still trading
0.9%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 4,107 companies, not a prediction for BUCAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0891633007
Change of role: , from manager to director
Resignation: (manager) · Director discharge: · Gazette deed
Registered office moved within Limal
New registered office: scavée de la Carrière, n° 2A, 1300 Limal · Previous registered office: rue de la Station, 17 à 1300 Limal · General meeting of 30-05-2020 · Gazette deed
Appointment: (manager)
General meeting of 20-11-2015 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BUCAMED Wavre | €657,143 | €82,995 | 18.4% | - |
| DRS. MENU - ISEBAERT Kruisem | €651,980 | €80,750 | 91.8% | - |
| Dokter Vanderperre Beringen | €633,177 | €77,865 | 38.4% | - |
| DR. CARL GOEMINNE Oudenaarde | €567,038 | €83,376 | 80.5% | - |
| Mersch-Mersch Médical Namur | €649,142 | €87,928 | 75.2% | - |
| DR. BIRGIT WIJGAERTS, ALGEMENE GENEESKUNDE Lummen | €581,007 | €75,205 | 81.9% | - |
| Dr. Els Bormans Haacht | €767,515 | €90,003 | 91.2% | - |
These companies have the same main activity as BUCAMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €567,000 and €768,000, founded between 2006 and 2010.
Official details
Source: KBO- Status
- Active since 03-08-2007Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.185.987.2481300 Wavre, since 03-08-2007
- Financial year end
- 30 June
- Peppol
- Reachable since 28-12-2025
Annual accounts to 30-06-2025
- €657,143▼ 1.6%
- Employeeson 30-06-2025
- 0
- Filing
- Filed on 30-01-2026, 1 day before the end of the filing period
Insights on BUCAMED
BUCAMED files the micro format. That format states no turnover. The gross margin rose from €44,891 in 2009 to €82,995 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BUCAMED
- What is the company number of BUCAMED?
- The company number of BUCAMED is 0891.633.007. The VAT number is the same number with BE in front: BE 0891.633.007.
- Where is BUCAMED based?
- The registered office is at Scavée de la Carrière 2A, 1300 Wavre.Company details
- What does BUCAMED do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of BUCAMED?
- BUCAMED is a private limited company (BV).
- When was BUCAMED founded?
- BUCAMED was founded on 03-08-2007.
- Is BUCAMED still active?
- Yes, BUCAMED is an active enterprise in the KBO register.
- What is the turnover of BUCAMED?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €82,995 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €240,000.Financials
- Is BUCAMED profitable?
- In financial year 2025, BUCAMED made a profit of €27,588.
- Where can I find the annual accounts of BUCAMED?
- BUCAMED filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BUCAMED due?
- BUCAMED must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.